http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Abdelmaksoud, Ahmed Hosni (검색결과 4 건)
- 무료
- 기관 내 무료
- 유료
-
Recurrent malignant solitary fibrous tumor of the scalp: a case report and literature review
Ahmed Rabie,Abdulkarim Hasan,Yasein Mohammed,Ayman Abdelmaksoud,Rabaan Ali A. 대한병리학회 2022 Journal of Pathology and Translational Medicine Vol.56 No.2
Solitary fibrous tumor (SFT) is a rare type of mesenchymal neoplasm that first was discovered in the pleura but can also affect the peritoneum, lungs, mediastinum, and skin. Cutaneous malignant SFT is an extremely rare tumor that resembles dermatofibrosacoma protuberance (DFSP) histologically and immunohistochemically. Herein, we describe a case of malignant SFT that presented as a recurrent mass on the scalp. The first lesion was totally excised one year before recurrence and was diagnosed as a DFSP based on the histopathology and cluster of differentiation 34 immunostaining positivity. Re-examination of the previously examined specimen was considered. Activator of transcription 6 positivity was also detected in the tissue, confirming the diagnosis of a recurrent malignant SFT rather than DFSP. There was no evidence of recurrence, locoregional, or distant metastases at six months after lesion removal with a safety margin.
-
Thermal Hydraulic Analysis of Core Flow Bypass in a Typical Research Reactor
Said M.A. Ibrahim,Salah El-Din El-Morshedy,Abdelfatah Abdelmaksoud 한국원자력학회 2019 Nuclear Engineering and Technology Vol.51 No.1
The main objective of nuclear reactor safety is to maintain the nuclear fuel in a thermally safe conditionwith enough safety margins during normal operation and anticipated operational occurrences. In thisresearch, core flow bypass is studied under the conditions of the unavailability of safety systems. As corebypass occurs, the core flow rate is assumed to decrease exponentially with a time constant of 25 s tonew steady state values of 20, 40, 60, and 80% of the nominal core flow rate. The thermal hydraulic codePARET is used through these calculations. Reactor thermal hydraulic stability is reported for all cases ofcore flow bypass.
-
Aziz, Ashraf Omar Abdel,Omran, Dalia,Nabeel, Mohamed Mahmoud,Elbaz, Tamer Mahmoud,Abdelmaksoud, Ahmed Hosni,Attar, Inas El,Shousha, Hend Ibrahim Asian Pacific Journal of Cancer Prevention 2016 Asian Pacific journal of cancer prevention Vol.17 No.5
Background: In the Barcelona Clinic Liver Cancer (BCLC) system, only sorafenib is suggested for HCC patients having performance status (PS) 1 or 2 even if they have treatable lesions. In the current study, we aimed to explore the outcome of using aggressive treatment for HCC patients with PS 1 and 2. Materials and Methods: Five hundred and twenty four patients with HCC were enrolled in this study and divided into 2 groups: 404 PS 1 and 120 PS 2. Of the included 524 patients, 136 recceived non-aggressive supportive treatment and sorafenib, while 388 patients were offered aggressive treatment in the form of surgical resection, transplantation, percutaneous ablation, trans-arterial chemoembolization and/or chemoperfusion. All the patients were followed up for a period of 2 years to determine their survival. Results: Most HCC patients were CHILD A and B grades (89.4% versus 85.0%, for PS1 and PS2, respectively). Patients with PS1 were significantly younger. Out of the enrolled 524 patients, 388 were offered aggressive treatment, 253 (65.2%) having their lesions fully ablated, 94 (24.2%) undergoing partial ablation and 41 patients with no ablation (10.6%). The median survival of the patients with PS 1 who were offered aggressive treatment was 20 months versus 9 months only for those who were offered supportive treatment and sorafenib (p<0.001). Regarding HCC patients with PS 2, the median survivals were similarly 19.7 months versus 8.7 months only (p<0.001). Conclusions: Aggressive treatment of HCC patients with PS 1 and 2 significantly improves their survival. Revising the BCLC guidelines regarding such patients is recommended.
-
Abdelaziz, Ashraf Omar,Elbaz, Tamer Mahmoud,Shousha, Hend Ibrahim,Ibrahim, Mostafa Mohamed,El-Shazli, Mostafa Abdel Rahman,Abdelmaksoud, Ahmed Hosni,Aziz, Omar Abdel,Zaki, Hisham Atef,Elattar, Inas An Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.9
Background: Hepatocellular carcinoma (HCC) is a dismal tumor with a high incidence, prevalence and poor prognosis and survival. Management of HCC necessitates multidisciplinary clinics due to the wide heterogeneity in its presentation, different therapeutic options, variable biologic behavior and background presence of chronic liver disease. We studied the different prognostic factors that affected survival of our patients to improve future HCC management and patient survival. Materials and Methods: This study is performed in a specialized multidisciplinary clinic for HCC in Kasr El Eini Hospital, Cairo University, Egypt. We retrospectively analyzed the different patient and tumor characteristics and the primary mode of management applied to our patients. Further analysis was performed using univariate and multivariate statistics. Results: During the period February 2009 till February 2013, 290 HCC patients presented to our multidisciplinary clinic. They were predominantly males and the mean age was $56.5{\pm}7.7years$. All cases developed HCC on top of cirrhosis that was mainly due to HCV (71%). Most of our patients were Child-Pugh A (50%) or B (36.9%) and commonly presented with small single lesions. Transarterial chemoembolization was the most common line of treatment used (32.4%). The overall survival was 79.9% at 6 months, 54.5% at 1 year and 22.4% at 2 years. Serum bilirubin, site of the tumor and type of treatment were the significant independent prognostic factors for survival. Conclusions: Our main prognostic variables are the bilirubin level, the bilobar hepatic affection and the application of specific treatment (either curative or palliative). Multidisciplinary clinics enhance better HCC management.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
